Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk? - Wikidata - wikimedia - TriplyDB

Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?

Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?

http://www.wikidata.org/entity/Q26777866

about

Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls.Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy Awareness and management of elevated blood pressure among human immunodeficiency virus-infected adults receiving antiretroviral therapy in urban Zambia: a call to action.Pituitary growth hormone (GH) secretion is partially rescued in HIV-infected patients with GH deficiency (GHD) compared to hypopituitary patients.HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.Heart aging measured with coronary artery calcium scoring and cardiovascular risk assessment algorithms in HIV infected patients Early vascular aging in the HIV infected: Is arterial stiffness assessment the ideal tool?HIV and Cardiovascular Disease: Role of Immunometabolic Perturbations.Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection.Antiretroviral therapy potentiates high-fat diet induced obesity and glucose intolerance.Metabolic and Cardiovascular Comorbidities Among Clinically Stable HIV Patients on Long-Term ARV Therapy in Five Ambulatory Clinics in Lima-Callao, Peru

P2860

Q33853259-785BDCF1-13B5-4132-A563-3B5A54B6AB46 Q36181422-CADA82F3-7144-45CF-81CC-1A104E291F4D Q38632513-0FCE92CA-641D-41C2-B1D2-879C9BD9B6AB Q38972764-6038BC98-DC6A-43C0-B125-43DC74DB754D Q39392100-F5265EAB-05E1-4FD0-8044-CE4566B43B31 Q39606522-960BF120-8724-4295-BEED-49155B12E705 Q40217543-7CEDEB28-6A7B-4087-A02E-C185697BF731 Q50045865-45235F9D-3192-4689-B87E-988BE66CCC42 Q51779710-EED2768A-AC49-4E54-9F22-934D46E95AA8 Q55292642-13293D59-8E36-4A81-BD73-2AA9601DBA82 Q59137576-9963F1FC-5A2B-412A-AE34-59F5CC2F5ACA

P2860

Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?

http://www.wikidata.org/entity/Q26777866

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Cardiovascular disease in huma ...... nts: A true or perceived risk?

@ast

Cardiovascular disease in huma ...... nts: A true or perceived risk?

@en

Cardiovascular disease in huma ...... nts: A true or perceived risk?

@nl

type

label

Cardiovascular disease in huma ...... nts: A true or perceived risk?

@ast

Cardiovascular disease in huma ...... nts: A true or perceived risk?

@en

Cardiovascular disease in huma ...... nts: A true or perceived risk?

@nl

prefLabel

Cardiovascular disease in huma ...... nts: A true or perceived risk?

@ast

Cardiovascular disease in huma ...... nts: A true or perceived risk?

@en

Cardiovascular disease in huma ...... nts: A true or perceived risk?

@nl

P1433

Q26777866-563DCB60-F7A3-45CC-8876-A1C73CD1C95A

P1476

Q26777866-DFF20A14-950E-4B1B-892A-0EE1C0C566F4

P2093

Q26777866-AA266BAC-B5BD-4FDB-83BF-4F111B88E364

Q26777866-D5B474E7-7227-4E8E-85D9-2BB0E0D3225E

Q26777866-D96BACAC-44C5-4CC4-BBA8-FD38C0286F77

Q26777866-EDEDB9A9-7378-428D-B41F-6D5344572794

P2860

Q26777866-01C4E641-C556-4E76-9665-A4988123C502

Q26777866-0367ED3F-9447-41FC-9E67-8B3275E1335A

Q26777866-048074F9-CD2A-443E-9809-406754696933

Q26777866-06263DCC-38CB-4C62-89FA-997C6BF97D3C

Q26777866-0BAD7DE4-E88E-4F79-BCF8-AC6CFA4E2F89

Q26777866-0CB4BFF2-20C4-4895-80A9-CE757FA97565

Q26777866-11F66469-1AAE-4D31-A54F-708A9F917935

Q26777866-12D99744-6FC5-4683-B1A7-EB77CEB3E081

Q26777866-1349697A-CA0F-4928-AA9A-F583941740AB

Q26777866-1421E974-E8DA-4797-AADF-215ACC86C78F

P304

Q26777866-BE09C1E5-186B-42E3-963B-965072DF99B9

P31

Q26777866-955CE3B6-6243-4286-AEF1-046CEFF59A02

P3181

Q26777866-F58F31CF-1261-4D64-AB1D-53BB4F45C0A3

P356

Q26777866-EED361F6-3CB4-46EC-BBC6-754016DA68E5

P407

Q26777866-6BF34F64-8FD6-41FA-AFA5-FE339A97F3B1

P433

Q26777866-6A8503C2-7112-4F3F-A9B1-917564BA4051

P478

Q26777866-636C1855-917E-49C9-B521-0EA97BA05694

P577

Q26777866-08956325-5324-4B7E-B775-124F7449E492

P5875

Q26777866-B7C83BE7-0936-4E34-861A-0A55A17046AC

P698

Q26777866-0FDABEE4-E304-48C0-A01A-E1255D6ADFE0

P921

Q26777866-11B7CB9E-84C4-48A6-B0A9-857D9F32AE09

Q26777866-D852197A-711B-4BB9-AC58-730E5E42077A

P932

Q26777866-E1F5E000-B167-4171-AD1E-9048ADCAB7E2

P3181

P356

P1433

World journal of cardiology

P1476

Cardiovascular disease in huma ...... nts: A true or perceived risk?

@en

P2093

Giovanni Guaraldi

http://www.w3.org/2001/XMLSchema#string

Marcella Manicardi

http://www.w3.org/2001/XMLSchema#string

Paolo Raggi

http://www.w3.org/2001/XMLSchema#string

Shima Shahbaz

http://www.w3.org/2001/XMLSchema#string

P2860

Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

HIV infection and the risk of acute myocardial infarction.

Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

CD4+ count-guided interruption of antiretroviral treatment

Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.

P304

633-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2689376

http://www.w3.org/2001/XMLSchema#string

P356

10.4330/WJC.V7.I10.633

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283337138

http://www.w3.org/2001/XMLSchema#string

P698

26516417

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

4620074

http://www.w3.org/2001/XMLSchema#string